ECRM_1170x120_8-1-17

AmerisourceBergen announces financial leadership change

Print Friendly, PDF & Email
VALLEY FORGE, Pa. — AmerisourceBergen Corporation announced that Tim Guttman, executive vice president and chief financial officer, has decided to retire from the company. James Cleary, executive vice president and group president, Global Commercialization Services and Animal Health, will succeed Guttman as executive vice president and chief financial officer. Guttman will step down as chief financial officer on November 9, 2018 and continue in an advisory capacity further into fiscal year 2019 to ensure a smooth transition. All previously communicated aspects of the company’s fiscal year 2018 financial guidance and assumptions remain the same.

“Tim has exemplified financial stewardship and humble leadership throughout his 16 years with the company. I have great respect for Tim’s energy, dedication and focus on financial performance.” said Steven Collis, chairman, president and chief executive officer of AmerisourceBergen. “During his nearly seven-year tenure as CFO, Tim has been a key partner to me, and the rest of the executive lead team, supporting the company in delivering a strong track record of financial results, growth and total shareholder return.”

Cleary joined AmerisourceBergen in February 2015 following the Company’s acquisition of MWI Veterinary Supply, where he served as chief executive officer for over a decade, leading MWI through its initial public offering, many years of growth and ultimate sale to AmerisourceBergen. Following the acquisition, Cleary served as executive vice president and president, AmerisourceBergen Animal Health for over two years until taking on responsibility for AmerisourceBergen’s pharmaceutical commercialization solutions for manufacturers and animal health as executive vice president and group president, Global Commercialization Services & Animal Health in June 2017.

“Jim brings more than 20 years of strong leadership and operational experience and an in-depth knowledge of our business to his new role as CFO,” Collis continued. “I feel fortunate to be able to have such an experienced executive transitioning into the CFO role. His proven track record of management and execution make him an excellent leader to help AmerisourceBergen continue to grow as a leading healthcare solutions provider and drive shareholder return.”




Comments are closed.